COMMUNIQUÉS West-GlobeNewswire

Rose Hill Life Sciences Appoints Jama Pitman as Chief Executive Officer
27/07/2026
Biopharma Veteran and Former Strategic Advisor Steps Up to Lead Organization as Rose Hill Advances Active Clinical Programs in Psychedelic Therapeutics BOSTON, July 27, 2026 (GLOBE NEWSWIRE) -- Rose Hill Life Sciences [...]
CurePSP Invests in the Next Generation of PSP and CBD Researchers with Student Fellowship Awards
27/07/2026
NEW YORK, July 27, 2026 (GLOBE NEWSWIRE) -- CurePSP has announced its latest student fellowship recipients, totaling seven projects between the Urso Student Fellowship Grant and the Jim Atwood Neuroscience Student [...]
SafeSpace Global Announces AI-Powered Senior Living Safety Pilot with Blakeford at Green Hills
27/07/2026
Knoxville, Tenn., July 27, 2026 (GLOBE NEWSWIRE) -- SafeSpace Global Corporation (“SafeSpace” or the “Company”) (OTCID: SSGC), a leader in multimodal AI-powered safety and security solutions dedicated to advancing [...]
Landmark 10-Year Study Strengthens Long-Term Evidence Supporting Focal Therapy
27/07/2026
Independent research from a UK group demonstrates durable long-term tissue ablation, while Sonablate’s extensive clinical use reflects its role in advancing HIFU technology worldwide CHARLOTTE, N.C., July 27, 2026 ( [...]
Revagenix Doses First Participant in Phase 1 Trial of Rev-56, an Inhaled Therapy for Non-CF Bronchiectasis
27/07/2026
— Potential first therapy to target chronic Pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis — Chronic Pseudomonas is a key driver of inflammation, exacerbations, and disease progression in bronchiectasis — [...]
HealthEx Launches HealthEx Wallet, a Secure App for Individuals to Access, Understand, and Manage Their Health Records
27/07/2026
Now available to individuals across HealthEx’s partner ecosystem, in the Medicare App Library, and launching soon directly from HealthEx WASHINGTON, July 27, 2026 (GLOBE NEWSWIRE) -- CMS Health Technology Ecosystem [...]
HealthEx to Help Americans Bring Their Medical Records into AskMD by Sharecare
27/07/2026
Partnership between Sharecare and HealthEx to support personalized and holistic healthcare navigation in AskMD WASHINGTON, July 27, 2026 (GLOBE NEWSWIRE) -- CMS Health Technology Ecosystem Event – July 27, 2026 – [...]
Parexel Recognized as a World’s Top Disability Inclusive Business by the Disability Index® from Disability:IN
27/07/2026
Reflecting company’s commitment to advancing inclusion and accessibility across its global workforce and in its clinical trials RALEIGH, N.C., July 27, 2026 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical [...]
Intuitive Collaborates with Deion “Coach Prime” Sanders to Raise Patient Awareness of Surgical Options
27/07/2026
Collaboration aims to help patients feel more informed, prepared and engaged in their care SUNNYVALE, Calif., July 27, 2026 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ: ISRG), a global technology leader in minimally invasive [...]
Sofwave to Participate in 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference
27/07/2026
SAN CLEMENTE, Calif., July 27, 2026 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (“the Company”) (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices for practitioners worldwide, today [...]
FDA Approves Freenome’s SimpleScreen™ CRC Blood-Based Screening Test; Abbott to Commercialize in the U.S.
27/07/2026
– Approval expands colorectal cancer screening options for the up to 60 million Americans who are overdue for screening – – Medicare coverage and American Cancer Society guidance support broader access to blood-based [...]
CytomX Therapeutics Announces Appointment of Charles Fuchs, M.D., M.P.H., to the Board of Directors
27/07/2026
SOUTH SAN FRANCISCO, Calif., July 27, 2026 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologics, today announced the appointment of Charles [...]
Genvor’s Antimicrobial Peptides Advance into Sugar Beet Research
27/07/2026
Woodland, CA, July 27, 2026 (GLOBE NEWSWIRE) -- Genvor, Inc. (OTCQB: GNVR) (“Genvor”), a biotechnology company harnessing AI to generate novel peptides that deliver high-performance solutions across agriculture and [...]
Inspire Medical Systems, Inc. Announces Appointment of Seasoned Medical Device Executive Michael H. Carrel to its Board of Directors
27/07/2026
Board appointment adds proven medical device leadership MINNEAPOLIS, July 27, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP), a medical technology company focused on innovative, minimally invasive [...]
Kyverna Therapeutics and ElevateBio Enter into Commercial Manufacturing and Supply Agreement for Miv-cel
27/07/2026
New agreement secures flexible and scalable manufacturing to support the U.S. commercial and global clinical supply of miv-cel EMERYVILLE, Calif., and WALTHAM, Mass., July 27, 2026 (GLOBE NEWSWIRE) -- Kyverna [...]
Oak Hill Bio and Research Alliance Corporation III Announce Business Combination Agreement to Create Publicly Listed Rare Disease Biotechnology Company to Advance Antisense Oligonucleotide Therapy Rugonersen for Angelman Syndrome
27/07/2026
Transaction to provide Oak Hill Bio with approximately $175 million in gross proceeds, including $75 million of cash in Research Alliance Corporation III’s (Nasdaq: RACC) (“RACC”) trust account that is fully backstopped [...]
Pacira BioSciences Advances PCRX-201 Development Program with Successful Transition to Scalable Commercial Manufacturing Process
27/07/2026
— First patient enrolled in Part B of Phase 2 ASCEND study enabled by availability of drug product from new manufacturing process — — Topline data from Part A of Phase 2 ASCEND study remains on track for end of year — [...]
Curium, in collaboration with nuclear cardiology leaders, announces immediate return of Thallous Chloride TI 201 Injection in the U.S. to support high-stakes cardiac imaging needs
27/07/2026
Reintroduction reflects clinician input and Curium investments to support reliable, long-term U.S. supply BOSTON, July 27, 2026 (GLOBE NEWSWIRE) -- Curium™ announced today the immediate reintroduction of Thallous [...]
Fortress Biotech and Subsidiary Urica Therapeutics Announce Crystalys Therapeutics’ $130 Million Series B Financing
27/07/2026
Proceeds to support ongoing late-stage global clinical development and commercialization preparation of dotinurad, a next-generation, once daily, oral URAT1 inhibitor with the potential to deliver best-in-class safety [...]

Pages